Mitochondrial pore and synaptic stress in Alzheimer's disease
阿尔茨海默病中的线粒体孔和突触应激
基本信息
- 批准号:8111441
- 负责人:
- 金额:$ 9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-15 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AD transgenic miceAddressAgeAlzheimer&aposs DiseaseAmyloid beta-ProteinAnimalsAttenuatedAxonBiological AssayCalciumDefectDendritic SpinesDevelopmentEnergy MetabolismEnvironmentFoundationsGenerationsGeneticHealthHippocampus (Brain)LearningMaintenanceMediatingMembraneMembrane PotentialsMemoryMentorsMitochondriaMitochondrial SwellingMorphologyMusNeuronsOxidative StressOxygen ConsumptionPathogenesisPathologyPermeabilityPlayPrincipal InvestigatorPropertyProteinsResearchResistanceRespirationRoleStressSynapsesSynaptic TransmissionTestingTransgenic MiceVertebral columnbasecareercell motilitycyclophilin Ddensityenzyme activityinsightmitochondrial dysfunctionmitochondrial membranemitochondrial permeability transition poremouse modelnovelnovel therapeutic interventionoverexpressionprogramsresponsesynaptic failuresynaptic functiontrafficking
项目摘要
DESCRIPTION (provided by applicant): Mitochondrial dysfunction and synaptic loss are early pathological features of Alzheimer's disease. Recent studies indicate that mitochondrial alterations in AD underlie Abeta-mediated synaptic pathology as evidenced by the observations: 1) significant correlation of mitochondrial dysfunction with synaptic loss in AD; and 2) the protection of mitochondria attenuates Abeta -induced synaptic changes. However, the mechanisms of Abeta -induced mitochondrial dysfunction and the consequent synaptic damages have not fully delineated. Notably, mitochondria in neurons are heterogeneous in their properties. A sub-group of neuronal mitochondria locating at synapses or namely synaptic mitochondria play a pivotal role in maintaining synaptic activity/function due to their physical proximity to synapses. Thus, to elucidate the mechanisms underlying Abeta -potentiated synaptic mitochondrial dysfunction is of great significance to deepen our understanding of the synaptic pathology in the pathogenesis of the AD. In the preliminary studies, we have demonstrated that synaptic mitochondria undergo increased propensity towards cyclophilin D (cypD)-mediated mitochondrial permeability transition pore (mPTP) in the Abeta milieu, transgenic AD mice overexpressing Abeta. Along with these changes, Abeta -insulted synaptic mitochondria underwent respiration defects. In addition, Abeta treatment resulted in decreased axonal mitochondrial density and the loss of synapses in cultured hippocampal neurons. As a contrast, these detrimental effects on synaptic mitochondrial and synaptic alterations were significantly attenuated by the blockade of cypD through genetic depletion of cypD. Thus, I have formulated a hypothesis that cypD-mediated mPTP is a potential mechanism underlying Abeta-induced synaptic mitochondrial dysfunction and synaptic alterations. To address this concept, I will utilize an AD mouse model (APP mice) and a novel genetically manipulated transgenic mouse model (genetic cypD-deficient APP mice) as well as cypD-deficiency hippocampal neuron cultures for the studies proposed in this application. This project contains three aims: 1). to determine the impact of cypD-mediated mPTP on synaptic mitochondrial function in APP mice; 2) to determine the impact of cypD-mediated mPTP on synaptic (axonal) mitochondrial dynamics and motility in Abeta milieus; and 3) to determine whether cypD-mediated synaptic mitochondrial dysfunction contributes to Abeta -induced synaptic alterations in APP mice. Upon the completion of this project, I will determine the involvement of cypD mediated mPTP in Abeta induced synaptic mitochondrial dysfunction, and the impact of cypD mediated mPTP on synaptic mitochondrial dynamics and motility, and synaptic function as well as animal learning/memory ability in APP/ Abeta overexpressing mice. Finding derived from this study will have positive impact on the development of new therapeutic approaches for AD treatment. This project will also serve as a firm foundation of my scientific career to establish a research direction distinct from my mentors' by the combination of synaptic mitochondrial dysfunction and synaptic alterations in AD.
描述(申请人提供):线粒体功能障碍和突触丢失是阿尔茨海默病的早期病理特征。最近的研究表明,AD中线粒体的改变是Abeta介导的突触病理的基础,观察表明:1)AD患者线粒体功能障碍与突触丢失显著相关;2)线粒体的保护减弱了Abeta诱导的突触变化。然而,Abeta诱导的线粒体功能障碍以及由此导致的突触损伤的机制尚未完全阐明。值得注意的是,神经元中的线粒体在性质上是不同的。位于突触的神经元线粒体的一个亚群,即突触线粒体,由于其物理上与突触的接近,在维持突触活动/功能方面发挥着关键作用。因此,阐明Abeta增强突触线粒体功能障碍的机制对于加深对AD发病机制中突触病理的认识具有重要意义。在初步研究中,我们已经证明在Abeta环境中,过度表达Abeta的转基因AD小鼠突触线粒体对亲环素D(CypD)介导的线粒体通透性转换孔(MPTP)的倾向增加。伴随着这些变化,Abeta诱导的突触线粒体出现了呼吸缺陷。此外,Abeta处理导致培养的海马神经元轴突线粒体密度降低和突触丢失。相比之下,这些对突触线粒体和突触改变的不利影响可以通过阻断cypD的基因缺失而显著减弱。因此,我提出了一个假设,即cypD介导的MPTP是Abeta诱导的突触线粒体功能障碍和突触改变的潜在机制。为了解决这一概念,我将利用AD小鼠模型(APP小鼠)和一种新的基因操纵的转基因小鼠模型(遗传cypD缺陷的APP小鼠)以及cypD缺乏的海马神经元培养来进行本申请中提出的研究。本项目包含三个目标:1)。目的:研究cypD介导的MPTP对APP小鼠突触线粒体功能的影响;2)研究cypD介导的MPTP对Aβ环境下突触(轴突)线粒体动力学和运动性的影响;3)确定cypD介导的突触线粒体功能障碍是否参与Aβ诱导的APP小鼠突触改变。本项目完成后,我将确定cypD介导的MPTP在Abeta诱导的突触线粒体功能障碍中的作用,以及cypD介导的MPTP对APP/Abeta高表达小鼠突触线粒体动力学和运动性、突触功能以及动物学习记忆能力的影响。这项研究的发现将对AD治疗新的治疗方法的发展产生积极的影响。这个项目也将作为我科学生涯的坚实基础,通过结合AD的突触线粒体功能障碍和突触改变来建立一个有别于我导师的研究方向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heng Du其他文献
Heng Du的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heng Du', 18)}}的其他基金
mtDNA leakage and STING-dependent microglial innate immune response in Alzheimer's disease
阿尔茨海默病中 mtDNA 渗漏和 STING 依赖性小胶质细胞先天免疫反应
- 批准号:
10549825 - 财政年份:2022
- 资助金额:
$ 9万 - 项目类别:
mtDNA leakage and STING-dependent microglial innate immune response in Alzheimer's disease
阿尔茨海默病中 mtDNA 渗漏和 STING 依赖性小胶质细胞先天免疫反应
- 批准号:
10346449 - 财政年份:2022
- 资助金额:
$ 9万 - 项目类别:
GHSR1a and Hippocampal Pathology in Alzheimer's Disease
阿尔茨海默病中的 GHSR1a 和海马病理学
- 批准号:
10163763 - 财政年份:2018
- 资助金额:
$ 9万 - 项目类别:
GHSR1a and hippocampal pathology in Alzheimer's Disease
阿尔茨海默病中的 GHSR1a 和海马病理学
- 批准号:
9762825 - 财政年份:2018
- 资助金额:
$ 9万 - 项目类别:
GHSR1a and Hippocampal Pathology in Alzheimer's Disease
阿尔茨海默病中的 GHSR1a 和海马病理学
- 批准号:
10393665 - 财政年份:2018
- 资助金额:
$ 9万 - 项目类别:
GHSR1a and hippocampal pathology in Alzheimer's Disease
阿尔茨海默病中的 GHSR1a 和海马病理学
- 批准号:
9918235 - 财政年份:2018
- 资助金额:
$ 9万 - 项目类别:
GHSR1a and Hippocampal Pathology in Alzheimer's Disease
阿尔茨海默病中的 GHSR1a 和海马病理学
- 批准号:
10266217 - 财政年份:2018
- 资助金额:
$ 9万 - 项目类别:
Mitochondrial ATP Synthase Dysfunction and Synaptic Stress in Alzheimer's Disease
阿尔茨海默病中的线粒体 ATP 合酶功能障碍和突触应激
- 批准号:
9160954 - 财政年份:2016
- 资助金额:
$ 9万 - 项目类别:
Mitochondrial ATP Synthase Dysfunction and Synaptic Stress in Alzheimer's Disease
阿尔茨海默病中的线粒体 ATP 合酶功能障碍和突触应激
- 批准号:
10266216 - 财政年份:2016
- 资助金额:
$ 9万 - 项目类别:
Mitochondrial pore and synaptic stress in Alzheimer's disease
阿尔茨海默病中的线粒体孔和突触应激
- 批准号:
8264172 - 财政年份:2011
- 资助金额:
$ 9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 9万 - 项目类别:
Research Grant